Home > Keywords > 
Catalog name Description price
R-C-2543 Agomelatine (S-20098) CAS:138112-76-2 Agomelatine(S-20098)is a specific agonist of MT1 and MT2 receptors with Kis of 0.1,0.06,0.12, and 0.27nM for CHO-hMT1,HEK-hMT1,CHO-hMT2,and HEK-hMT2,respectively.Agomelatine is a selective 5-HT2C receptor antagonist with pKis of 6.4 and 6.2 at native(porcine)and cloned, human 5-HT2C receptors, respectively. price>
R-R-4243 ACT-1004-1239 CAS No.2178049-58-4 ACT-1004-1239/CAS No.2178049-58-4 is a potent, selective, orally active CXCR7 antagonist with an IC50 value of 3.2 nM. price>
R-C-2544 Escitalopram oxalate CAS:219861-08-2 Escitalopram Oxalate is a furancarbonitrile that is one of the selective serotonin uptake inhibitors used as an antidepressant.As a selective serotonin reuptake inhibitor(SSRI),escitalopram blocks the reuptake of serotonin by neurons in the central nervous system(CNS),thereby potentiating CNS serotonergic activity. price>
R-R-4244 NUCC-390 dihydrochloride CAS No.2749281-71-6 NUCC-390 dihydrochloride/CAS No.2749281-71-6 is a novel and selective small-molecule CXCR4 receptor agonist. NUCC-390 dihydrochloride induces internalization of CXCR4 receptors and acts in an opposite way of AMD3100 (HY-10046). NUCC-390 dihydrochloride promotes nerve recovery of function after neurodegeneration in vivo. price>
R-C-2545 Clemizole CAS:442-52-4 Clemizole is an H1 histamine receptor antagonist,is found to substantially inhibit HCV replication.The IC50 of Clemizole for RNA binding by NS4B is 24±1nM,whereas its EC50 for viral replication is 8µM. price>
R-R-4245 SB-265610 CAS No.211096-49-0 SB-265610/CAS No.211096-49-0 is a selective, competitive, nonpeptide and allosteric CXCR2 antagonist. SB-265610 blocks rat cytokine-induced neutrophil chemoattractant-1 (CINC-1)-induced calcium mobilization and neutrophil chemotaxis with IC50s of 3.7 nM and 70 nM, respectively. price>
R-C-2546 J147 CAS:1146963-51-0 J-147 is an exceptionally potent,orally active, neuroprotective agent for cognitive enhancement.J-147 can readily pass the blood brain barrier(BBB).J-147 can inhibit monoamine oxidase B(MAO B)and the dopamine transporter with EC50 values of 1.88μM and 0.649μM,respectively. price>
R-R-4246 CXCR7 antagonist-1 CAS No.1613021-99-0 CXCR7 antagonist-1/CAS No.1613021-99-0 is a CXCR7 antagonist that inhibits the binding of the SDF-1 chemokine (also known as the CXCL12 chemokine) or I-TAC (also known as CXCL11) to the chemokine receptor CXCR7. CXCR7 antagonist-1 is useful in preventing tumor cell proliferation, tumor formation, inflammatory diseases, and many other diseases (extracted from patent WO2014085490A1, compound 1.128). price>
R-C-2547 NS11394 CAS:951650-22-9 NS-11394 is a drug which acts as a subtype-selective positive allosteric modulator at GABAA receptors,with selectivity for the α3 and α5 subtypes. NS11394 has a unique subtype-selective GABA(A)receptor profile and represents an excellent pharmacological tool to further understanding on the relative contributions of GABA(A)receptor subtypes in various therapeutic areas. price>
R-R-4247 ML 145 CAS No.1164500-72-4 ML 145/CAS No.1164500-72-4 is a selective and competitive human GPR35/CXCR8 antagonist with an IC50/EC50 of 20.1 nM. ML 145 has over 1000-fold more selective for GPR35 compared to GPR55 (IC50/EC50=21.7 μM). ML 145 has no significant activity for GPR35 at either rodent ortholog. price>
R-C-2548 TG6-10-1 CAS:1415716-58-3 TG6-10-1 is an EP2 antagonist,shows low-nanomolar antagonist activity against only EP2,>300-fold selectivity over human EP3,EP4,and IP receptors,100-fold selectivity over EP1 receptors. price>
R-R-4248 NBI-74330 CAS No.855527-92-3 NBI-74330/CAS No.855527-92-3 is a potent antagonist for CXCR3, and exhibits potent inhibition of (125I)CXCL10 and (125I)CXCL11 specific binding with Ki of 1.5 and 3.2 nM, respectively. price>
R-C-2549 Elacridar HCl CAS:143851-98-3 Elacridar(GF120918A)is a P-glycoprotein(P-gp)inhibitor,and has been used both in vitro and in vivo as a tool inhibitor of P-glycoprotein(Pgp)to investigate the role of transporters in the disposition of various test molecules.In vitro, GF120918A demonstrated high plasma protein binding across species,although a definitive protein binding evaluation was precluded by poor recovery, particularly in buffer and in mouse,rat,and dog plasma.GF120918A did not demonstrate potent inhibition of several human cytochrome P450 enzymes evaluated in vitro,with IC(50)values well above concentrations anticipated to be achieved in vivo.Together,these data confirm the utility of GF120918A as a tool P-glycoprotein inhibitor in preclinical species and offer additional guidance on preclinical dose regimens likely to produce P-glycoprotein-mediated effects. price>
R-R-4249 VUF11207 fumarate CAS No.1785665-61-3 VUF11207 fumarate/CAS No.1785665-61-3 is a CXCR7 agonist that binds specifically to CXCR7. VUF11207 fumarate reduces CXCL12-mediated osteoclastogenesis and bone resorption by inhibiting ERK phosphorylation. price>
R-C-2550 Muscimol HBr CAS:18174-72-6 Muscimol hydrobromide is a potent but toxic structural analog of g-aminobutyric acid(GABA),with a zwitterionic structure. price>
R-R-4250 IT1t dihydrochloride CAS No.1092776-63-0 IT1t dihydrochloride/CAS No.1092776-63-0 is a potent CXCR4 antagonist; inhibits CXCL12/CXCR4 interaction with an IC50 of 2.1 nM. price>
R-C-2551 Epirubicin hydrochloride CAS:56390-09-1 Epirubicin is a cell-permeable anthracycline antitumor antibiotic.It is a stereoisomer(4-epi-isomer)of doxorubicin that exhibits reduced cardiotoxicity.It is used to inhibit topoisomerase II and DNA helicase activity. price>
R-R-4251 PS372424 hydrochloride CAS No.1596362-29-6 PS372424 hydrochloride/CAS No.1596362-29-6, a three amino-acid fragment of CXCL10, is a specific human CXCR3 agonist with anti-inflammatory activity. PS372424 hydrochloride prevents human T-cell migration in a humanized model of arthritic inflammation. price>
R-C-2552 AZD7762 CAS:860352-01-8 AZD-7762 is a synthetic small molecule inhibitor of checkpoint kinases(Chks)with potential chemosensitizing activity.AZD7762 binds to and inhibits Chks,which may prevent cell cycle arrest and subsequent nucleotide excision repair in DNA-damaged tumor cells,resulting in tumor cell apoptosis.This agent may enhance the cytotoxicity of DNA-damaging agents.Chks are protein kinases that regulate either G1/S or G2/M transitions in the cell cycle. In the presence of DNA damage or incomplete DNA replication,Chks become activated and initiate cell cycle arrest to allow DNA repair or the completion of DNA replication. price>
R-R-4252 Reparixin L-lysine salt CAS No.266359-93-7 Reparixin L-lysine salt/CAS No.266359-93-7 is an allosteric inhibitor of chemokine receptor 1/2 (CXCR1/2) activation. price>